The median survivals were 8 months and 6 months respectively and did not reach statistical significance.
← all excerpts
Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma.
1
—
—
The median survivals were 8 months and 6 months respectively and did not reach statistical significance.